Cite
Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine
MLA
Cavaleri, D., et al. Evidence from Preclinical and Clinical Metabolomics Studies on the Antidepressant Effects of Ketamine and Esketamine. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1434546053&authtype=sso&custid=ns315887.
APA
Cavaleri, D., Riboldi, I., Crocamo, C., Paglia, G., Carrà, G., Bartoli, F., Cavaleri D., Riboldi I., Crocamo C., Paglia G., Carrà G., & Bartoli F. (2024). Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine.
Chicago
Cavaleri, D, I Riboldi, C Crocamo, G Paglia, G Carrà, F Bartoli, Cavaleri D., et al. 2024. “Evidence from Preclinical and Clinical Metabolomics Studies on the Antidepressant Effects of Ketamine and Esketamine.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1434546053&authtype=sso&custid=ns315887.